Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00176956 · ClinicalTrials.gov registry record · Phase 3

Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients

A Phase 3 study, sponsored by Hordinsky, Maria K., MD.

Terminated
Registry status
Phase 3
Development phase
30
Enrollment target

NCT00176956: Clinical Trial Phase 3 study, sponsored by Hordinsky, Maria K., MD.

NCT00176956 is a Phase 3 study that was terminated before completion, run by Hordinsky, Maria K., MD. The registered enrollment target is 30 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00176956, a Phase 3 study, was terminated before completion, sponsored by Hordinsky, Maria K., MD.

TERMINATED
Registry status
Phase 3
Development phase
30 participants
Enrollment target

Study Summary

The skin disease found in pediatric heart transplant patients represents an atopic dermatitis-like rash that is refractory to systemic immunomodulation.

Interventions

  • PROCEDURE Skin Biopsy

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2002-11
Est. Completion 2007-01
Phase Phase 3
Hordinsky, Maria K., MD

7 total trials

Why NCT00176956 stopped before completion

NCT00176956 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Skin Biopsy is the first listed.

NCT00176956 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00176956 about?

NCT00176956 is a clinical study titled "Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients". The skin disease found in pediatric heart transplant patients represents an atopic dermatitis-like rash that is refractory to systemic immunomodulation.

What is the current status of trial NCT00176956?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2002-11. Estimated completion is 2007-01.

What interventions are being tested in trial NCT00176956?

The interventions under investigation include: Skin Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT00176956?

This trial is sponsored by Hordinsky, Maria K., MD, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00176956's enrollment target sits among peer trials

30 1917th of 2000 higher than 68 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00176956, the US trial registry maintained by the National Library of Medicine. NCT00176956 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.